Literature DB >> 20181974

Graves' ophthalmopathy.

Rebecca S Bahn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20181974      PMCID： PMC3902010          DOI： 10.1056/NEJMra0905750

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  115 in total

1.  Present concepts of the pathologic physiology of exophthalmos.

Authors:  B M DOBYNS
Journal:  J Clin Endocrinol Metab       Date:  1950-10       Impact factor: 5.958

2.  Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.

Authors:  Seema Kumar; Alexey Leontovich; Michael J Coenen; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

Review 3.  Design of effective immunotherapy for human autoimmunity.

Authors:  Marc Feldmann; Lawrence Steinman
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

4.  Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor.

Authors:  R W Valyasevi; D Z Erickson; D A Harteneck; C M Dutton; A E Heufelder; S C Jyonouchi; R S Bahn
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

5.  Thyrotropin receptor expression in adrenal, kidney, and thymus.

Authors:  C M Dutton; W Joba; C Spitzweg; A E Heufelder; R S Bahn
Journal:  Thyroid       Date:  1997-12       Impact factor: 6.568

6.  Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

Authors:  Bart Keymeulen; Evy Vandemeulebroucke; Anette G Ziegler; Chantal Mathieu; Leonard Kaufman; Geoff Hale; Frans Gorus; Michel Goldman; Markus Walter; Sophie Candon; Liliane Schandene; Laurent Crenier; Christophe De Block; Jean-Marie Seigneurin; Pieter De Pauw; Denis Pierard; Ilse Weets; Peppy Rebello; Pru Bird; Eleanor Berrie; Mark Frewin; Herman Waldmann; Jean-François Bach; Daniel Pipeleers; Lucienne Chatenoud
Journal:  N Engl J Med       Date:  2005-06-23       Impact factor: 91.245

Review 7.  Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology.

Authors:  Chris Knouff; Johan Auwerx
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

8.  Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production.

Authors:  G D Sempowski; J Rozenblit; T J Smith; R P Phipps
Journal:  Am J Physiol       Date:  1998-03

9.  Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.

Authors:  R S Bahn; C M Dutton; N Natt; W Joba; C Spitzweg; A E Heufelder
Journal:  J Clin Endocrinol Metab       Date:  1998-03       Impact factor: 5.958

10.  Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.

Authors:  Glynn Baker; Gherardo Mazziotti; Chris von Ruhland; Marian Ludgate
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736
View more
  388 in total

1.  Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.

Authors:  Xiaoming Yin; Rauf Latif; Rebecca Bahn; Terry F Davies
Journal:  Thyroid       Date:  2012-06-04       Impact factor: 6.568

2.  Orbital decompression for Graves' orbitopathy in England.

Authors:  P Perros; T Chandler; C M Dayan; A J Dickinson; P Foley; J Hickey; C J Macewen; J H Lazarus; J McLaren; G E Rose; J M Uddin; B Vaidya
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

Review 3.  Environmental exposures and autoimmune thyroid disease.

Authors:  Gregory A Brent
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

4.  Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

Authors:  Terry J Smith; Dolly A Padovani-Claudio; Ying Lu; Nupur Raychaudhuri; Roshini Fernando; Stephen Atkins; Erin F Gillespie; Andrew G Gianoukakis; Barbra S Miller; Paul G Gauger; Gerard M Doherty; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

5.  Computer-Assisted Three-Dimensional Planning for Orbital Decompression.

Authors:  Nicholas Mahoney; Michael P Grant; Srinivas Murthy Susarla; Shannath Merbs
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-11-14

6.  Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Masahito Ohji
Journal:  Jpn J Ophthalmol       Date:  2015-09-01       Impact factor: 2.447

7.  Chemodenervation of extraocular muscles with botulinum toxin in thyroid eye disease.

Authors:  David B Granet; Nickisa Hodgson; Kyle J Godfrey; Ricardo Ventura; Don O Kikkawa; Leah Levi; Michael Kinori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-10       Impact factor: 3.117

Review 8.  Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies.

Authors:  Terry F Davies; Rauf Latif
Journal:  Expert Opin Ther Targets       Date:  2015-03-13       Impact factor: 6.902

9.  Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.

Authors:  Mario Salvi; Guia Vannucchi; Nicola Currò; Irene Campi; Danila Covelli; Davide Dazzi; Simona Simonetta; Claudio Guastella; Lorenzo Pignataro; Sabrina Avignone; Paolo Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  2014-12-15       Impact factor: 5.958

10.  Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins.

Authors:  Christine C Krieger; Susanne Neumann; Robert F Place; Bernice Marcus-Samuels; Marvin C Gershengorn
Journal:  J Clin Endocrinol Metab       Date:  2014-12-08       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.